Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANPA | Rich Sparkle | $12.51 | $4.33 | 52.93% | 3.7M | $102M | $2.80$180.64 |
| BNAI | Brand Engagement Network | $28.20 | $8.09 | 40.23% | 4.6M | $90M | $1.18$86.28 |
| CLVT | Clarivate Plc | $2.35 | $0.67 | 39.88% | 45M | $1.1B | $1.66$4.77 |
| PVLA | Palvella Therapeutics | $120.52 | $32.68 | 37.20% | 96K | $1.0B | $18.23$127.50 |
| FGL | Founder Group | $11.60 | $2.96 | 34.26% | 1.9M | $1.5M | $7.03$155.00 |
| GANX | Gain Therapeutics | $2.76 | $0.67 | 31.82% | 88.1K | $80M | $1.41$4.34 |
| LRMR | Larimar Therapeutics | $3.68 | $0.87 | 30.96% | 1.8M | $241M | $1.61$5.37 |
| GITS | Global Interactive Technologies | $3.05 | $0.72 | 30.90% | 333.4K | $8.6M | $0.66$7.09 |
| IOVA | Iovance Biotherapeutics | $3.76 | $0.87 | 30.10% | 2.2M | $1.1B | $1.64$5.64 |
| VIR | Vir Biotechnology | $9.49 | $2.06 | 27.73% | 38.3M | $1.0B | $4.16$10.29 |
| HSPTU | Horizon Space Acquisition II Corp. | $12.51 | $2.70 | 27.52% | 1.9K | $89M | $9.50$13.00 |
| TBMC | Trailblazer Merger I | $12.81 | $2.70 | 26.71% | 16.6K | $25M | $7.77$14.91 |
| CIFG | Themes ETF Trust - Leverage Shares 2x Long Cifr Daily ETF | $9.87 | $2.00 | 25.50% | 145.1K | - | $5.66$16.08 |
| MBOT | Microbot Medical | $2.55 | $0.50 | 24.15% | 283.6K | $138M | $1.25$4.67 |
| AXTI | AXT | $35.08 | $6.65 | 23.39% | 9.8M | $1.6B | $1.13$35.08 |
| KEYS | Keysight Technologies | $301.48 | $56.48 | 23.05% | 6.1M | $42B | $121.43$305.37 |
| FIGG | Themes ETF Trust - Leverage Shares 2x Long Fig Daily ETF | $2.18 | $0.40 | 22.47% | 5.2M | - | $1.18$16.34 |
| JWEL | Jowell Global | $2.29 | $0.38 | 19.89% | 39.5K | $4.1M | $1.47$3.03 |
| LACG | Themes ETF Trust - Leverage Shares 2x Long Lac Daily ETF | $12.26 | $2.02 | 19.77% | 16.3K | - | $9.55$26.22 |
| BGMSP | Bio Green Med Solution | $3.69 | $0.59 | 19.03% | 1.2K | - | $2.95$17.00 |
| NCTY | The9 | $5.99 | $0.95 | 18.85% | 57 | $75M | $5.00$15.98 |
| RVSN | Rail Vision | $7.42 | $1.16 | 18.53% | 92.7K | $14M | $3.66$29.57 |
| RIME | Algorhythm Holdings, Inc. | $2.18 | $0.34 | 18.48% | 42.2M | $5.0M | $0.73$4.58 |
| CRWG | Themes ETF Trust - Leverage Shares 2x Long Crwv Daily ETF | $4.44 | $0.69 | 18.40% | 10.5M | - | $2.42$19.63 |
| HRTG | Heritage Insurance | $27.73 | $4.27 | 18.20% | 25.9K | $725M | $9.89$31.98 |
| BLBX | Blackboxstocks | $18.15 | $2.75 | 17.86% | 822.9K | $66M | $2.48$18.92 |
| AMUU | Direxion Shares ETF Trust - Direxion Daily Amd Bull 2x Shares | $49.33 | $7.47 | 17.84% | 628.5K | - | $11.12$101.84 |
| AMDG | Themes ETF Trust - Leverage Shares 2x Long Amd Daily ETF | $23.78 | $3.58 | 17.72% | 423.5K | - | $5.31$49.00 |
| AMDL | GraniteShares ETF Trust - GraniteShares 2x Long Amd Daily ETF | $14.03 | $2.09 | 17.50% | 29.9M | - | $2.77$25.86 |
| IBRX | ImmunityBio | $11.54 | $1.71 | 17.34% | 1.8M | $9.7B | $1.83$12.27 |
| HSPT | Horizon Space Acquisition II Corp. | $12.49 | $1.72 | 15.97% | 1.8K | $98M | $9.51$14.31 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around?
David Jagielski, CPA|Nov 11, 2025
Iovance has a long way to go to get to a break-even point, but the company has been showing progress.
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street
Prosper Junior Bakiny|Nov 7, 2025
Wall Street may be overestimating these companies' potential.
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
Prosper Junior Bakiny|Oct 17, 2025
Is there a glimmer of hope for either of these underperforming healthcare companies?
Can This Beaten-Down Stock Bounce Back?
Prosper Junior Bakiny|Sep 19, 2025
This biotech company is innovative, but the market demands more than that.
If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today
Eric Volkman|Aug 27, 2025
The company hasn't been popular among investors since winning its first FDA approval more than a year ago.
1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street
Prosper Junior Bakiny|Aug 24, 2025
Time is running out for the company to mount a comeback.
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
James Brumley|Aug 9, 2025
All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth.
Is Iovance Biotherapeutics Stock Due for a Big Rally?
David Jagielski, CPA|Jul 30, 2025
The biotech stock has been picking up steam of late -- but will it last?
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?
Cory Renauer|Jul 29, 2025
Even the average price estimate for this stock suggests it can soar, but not everyone's convinced.
